3.24 USD
↗ 0.04 (1.25%)AT CLOSE (03:59 PM EDT)
X4 Pharmaceuticals, Inc. Common Stock
XFORNASDAQ • USD
3.18
↘ 0.07 (2.01%)
POST MARKET (AS OF 07:31 PM EDT)
Post Market
AS OF 07:31 PM EDT
3.18
↘ 0.07 (2.01%)
Market: CLOSED
Shares of X4 Pharmaceuticals, Inc. Common Stock (XFOR) are trading at $3.24. The technical outlook is "Buy" and the fundamental picture shows "Neutral". This is driven by a concerning Altman Z-Score in the distress zone, negative Return on Equity and a bearish Death Cross on the long-term moving averages. On valuation, XFOR trades roughly in line with sector averages — neither particularly cheap nor expensive.
Technical & fundamental data as of Oct 23, 2026.
Open?$3.16
High?$3.25
Low?$3.02
Prev. Close?$3.20
Volume?536.8K
Avg. Volume?914.7K
VWAP?$3.23
Rel. Volume?0.59x
Bid / Ask
Bid?$3.02 × 1.0K
Ask?$3.99 × 8.9K
Spread?$0.97
Midpoint?$3.51
Valuation & Ratios
Market Cap?321.2M
Shares Out?99.1M
Float?80.5M
Float %?81.2%
P/E Ratio?N/A
P/B Ratio?2.07
EPS?-$0.91
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
X4 Pharmaceuticals Inc is a biopharmaceutical company developing and commercializing novel therapeutics for the treatment of rare hematology diseases. The Company's clinical candidate is mavorixafor, a small molecule antagonist of the chemokine receptor CXCR4 that is being developed as an oral, once-daily therapy. It can increase the mobilization of mature, functional white blood cells from the bone marrow into the bloodstream. It also has two pre-clinical candidates X4P-003 and X4P-002 which are CXCR4 antagonists with different properties.
Employees
45
Market Cap
321.2M
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Website
Listed
2017-11-16
Address
61 NORTH BEACON STREET
BOSTON, MA 02134
Phone: 857-529-8300
BOSTON, MA 02134
Phone: 857-529-8300
Technical OutlookBuy
Strong SellNeutralStrong Buy
Long-Term (Tide)?– Neutral(0/3)
Medium-Term (Wave)?▲ Bullish(+1/3)
Short-Term (Ripple)?▲ Bullish(+3/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?23
Z-Score?0
Momentum?97
Short Sent.?59
Piotroski F-Score?3/9Weak
Altman Z-Score?-1.65Distress
Confidence?51%Low
Short InterestHigh
Short % of Float?9.43%Elevated
Short Interest?7.6M
Days to Cover?6.0
Free Float80.5M
Avg Daily Volume1.3M
Settlement Date2026-09-30
Financial Health
Current Ratio?11.30Strong
Quick Ratio?11.02Strong
Cash Ratio?10.07Strong
Debt/Equity?0.49Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score67/100
P/E?N/A▾
P/B?2.07CHEAP▾
Peers100
S&P73
P/S?20.27HIGH▾
Peers100
S&P3
P/FCF?N/A▾
EV/EBITDA?-2.4CHEAP▾
S&P97
EV/Sales?12.80HIGH▾
Peers100
S&P6
Returns & Efficiency
ROE?-58.0%WEAK▾
S&P3
ROA?-35.6%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-83736000
Enterprise Value?$202.9M
Fundamentals ratios updated end of day